Welcome to IsraPharm - Contact us at +972 7337 468 45 (Office)

Contact Us

Office Address

Weizman 14 st., Tel Aviv, Israel

Phone Number

+972 7337 46845 (Office)

Email Address

[email protected]



Add to Wishlist
Add to Wishlist


Picray in combination with fulvestrant is indicated for the treatment of postmenopausal women and men with hormone receptor positive (HR+), human epidermal growth factor receptor type 2 (HER2-) negative advanced or metastatic PIK3CA (PIK3CA+) mutated breast cancer. ) with disease progression during/after endocrine therapy regimens.

Active ingredient: alpesinib

Prescription medicine.

Additional information


150 Mg, 200 Mg